Shares of Hims & Hers Health Inc. rallied after hours on Monday, after the online wellness platform said 2024 would be its first year of positive net income and forecast first-quarter and full-year sales that were above expectations. That forecast came after the telehealth company — which offers health consultations and sells hair-loss, weight-loss and anxiety treatments, as well as sexual-health drugs like Viagra, through its Hims and Hers websites — reported its first-ever quarter of positive net income.H ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ____________ HIMS & HERS HEALTH, INC. (Exact name of registrant as specified in its charter) | Delaware | 001-38986 | | 98-1482650 | | --- | --- | --- | ...

Financial Performance - Revenue for the full year 2023 was $872.0 million, representing a 65% increase year-over-year[1] - Total revenue for Q4 2023 was $246.6 million, a 47% increase from $167.2 million in Q4 2022[7] - Total revenue for the year ended December 31, 2023, was $872 million, a 65% increase from $526.9 million in 2022[28] - Net income for Q4 2023 was $1.2 million, compared to a net loss of $(10.9) million in Q4 2022[7] - Net loss for the year was $23.5 million, an improvement from a net loss of $65.7 million in 2022[31] - The company reported a net income (loss) as a percentage of revenue of (3%) for the year ended December 31, 2023, compared to (12%) in 2022[36] Subscriber Growth - Subscribers reached 1.5 million by the end of Q4 2023, a 48% increase year-over-year[3] EBITDA and Cash Flow - Adjusted EBITDA for Q4 2023 was $20.6 million, up from $3.9 million in Q4 2022[7] - Adjusted EBITDA guidance for full year 2024 is projected to be between $100 million and $120 million[15] - Free Cash Flow for the full year 2023 was $47.0 million, compared to $(33.8) million in 2022[7] - Free Cash Flow for Q4 2023 was $10,785,000, a significant improvement from a negative Free Cash Flow of $(9,332,000) in Q4 2022[38] - Net cash provided by operating activities for the year ended December 31, 2023, was $73,483,000, compared to $(26,531,000) in 2022[38] Margins and Expenses - Gross margin for the full year 2023 was 82%, compared to 78% in 2022[7] - Monthly Online Revenue per Average Subscriber for Q4 2023 was $53, a 4% decrease from Q4 2022[3] - Operating expenses for the year totaled $744.4 million, up from $477.4 million in 2022, with marketing expenses increasing to $446.4 million[28] - Stock-based compensation for the year ended December 31, 2023, was $66,080,000, an increase from $42,817,000 in 2022[36] - Depreciation and amortization for the year ended December 31, 2023, was $9,515,000, compared to $7,474,000 in 2022[36] - Acquisition-related costs for the year ended December 31, 2023, totaled $3,016,000, up from $1,192,000 in 2022[36] Assets and Liabilities - Cash and cash equivalents at the end of the period were $96.7 million, up from $46.8 million at the end of 2022[31] - Total assets increased to $441.2 million in 2023, compared to $366.3 million in 2022[27] - Total liabilities rose to $97.2 million, up from $54.6 million in 2022[27] - Stockholders' equity increased to $344 million, compared to $311.7 million in 2022[27] Future Outlook - The company expects full year 2024 revenue to be in the range of $1.17 billion to $1.20 billion[1] - Future cash outflows are expected to be similar to the adjustments presented, impacting future results[37]

Cecilie_Arcurs/E+ via Getty Images A few months ago, we wrote an article about Hims & Hers Health (NYSE:HIMS) titled: "Hims & Hers: 3 Reasons To Buy This Potential Growth Stock". In that article, we made the case that the stock was incredibly undervalued when compared to the company's growth opportunity and TAM over the long term. Since then, the stock has rallied more than 50%, as we were lucky enough to catch nearly the exact bottom with our article: Seeking Alpha However, while HIMS's market opportun ...

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced Dan Kenger will join the company’s executive team as the first Chief Design Officer. Kenger currently serves as the SVP of Design at Hims & Hers and has been at the company since its founding. “ I started at Hims & Hers seven years ago with a commitment to deliver a truly thoughtful, accessible, personalized experience to every person who interacts with our brand,” ...

Chinnapong/iStock via Getty ImagesIntro Hims & Hers Health (NYSE:HIMS) is a pioneering player in the telehealth sector that has been making waves in the healthcare industry. Operating in the vast and rapidly expanding telehealth market, we believe HIMS is well-positioned as an early-stage disruptor with a unique approach to providing accessible healthcare solutions. The company generates revenue through its innovative platform, offering a range of telehealth services, including consultations, prescripti ...

Long-term investing is the key to sustainable returns in the stock market because it smooths out near-term volatility and gives a company time to deliver on its growth or profit potential. This strategy can be particularly useful for smaller growth stocks like Hims & Hers (HIMS -2.17%).Let's discuss what the next five years could hold for this unique company as it scales its business model and swings toward sustainable profitability. What is Hims & Hers?Founded in 2017, Hims & Hers is a telemedicine company ...

SAN FRANCISCO & HARTFORD, Conn.--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, and Connecticut’s most transformative health system, Hartford HealthCare (HHC), today announced a strategic partnership that broadens access to in-person healthcare services. The collaboration provides patients with an enhanced and connected healthcare experience when they need care outside the Hims & Hers platform. Licensed medical providers on the platform wi ...

Hims & Hers Health, Inc. (HIMS) shares ended the last trading session 8.3% higher at $9.64. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 0.1% gain over the past four weeks.Hims & Hers Health scored a strong price increase, on investors’ optimism driven by the company’s newly launched Weight Loss program — a comprehensive and customizable clinical approach developed with expert insights to help people achieve the ...

People can and should consider what Wall Street analysts say about a stock. After all, these analysts are the professionals of the investing world and are compensated very well for their research and opinions.But that doesn't mean that they're always right. In fact, it looks like they may have made a jaw-dropping mistake with Hims & Hers Health (HIMS -1.44%), an up-and-coming telehealth company that doesn't have the mainstream attention bigger companies have.The evidence overwhelmingly points to the company ...